RecruitingNCT07122531
Ketone supplements with antipsychotic treatment for first-episode psychosis
About this title
Read the official source — NCT07122531Interventional studyAges 18–35CanadaSchizophrenia
Understand this study
Who could participate?
Listed age limits: 18 years to 35 years.
- Listed locations
- SherbrookeSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: August 26, 2025
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 15
- Sponsor
- Université de Sherbrooke
- Sponsor type
- University
- Study type
- Other
- Intervention type
- Other
- Locations
- Canada
- Age range
- From 18 Years to 35 Years
- Official registry ID
- NCT07122531
- Official title
Show the full official title
Metabolic and Clinical Evaluation of Medium-Chain Triglyceride-Based Exogenous Ketone Supplementation as an Adjunctive Treatment for First-Episode Psychosis
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Sherbrooke
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Université de Sherbrooke, a university.
Who can participate?
Listed age limits: 18 years to 35 years.
Is this study still recruiting?
The registry lists this study as recruiting.
